Application Note: Automated Antibody Verification for Lead Discovery
4 January 2013

Monoclonal antibodies play an increasing role as therapeutic agents in the pharmaceutical industry. Several steps within the antibody lead discovery and optimization process require the expression, purification and analytical characterization of the respective antibodies or antibody fragments. This application note presents a fully automated workflow for antibody verification using the micrOTOF-Q II from Bruker Daltonics.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me